Related Experiment Videos
Stem cells engineered to express self-antigen to treat autoimmunity
Frank Alderuccio1, Kim Murphy, Ban-Hock Toh
1Department of Pathology and Immunology, Monash University Medical School, Victoria 3181, Australia.
Trends in Immunology
|April 17, 2003
Summary
This study proposes a novel curative strategy for autoimmune diseases, combining hematopoietic stem cells and gene therapy to induce immunological tolerance. This approach aims to prevent disease relapse, offering an advancement over current treatments.
Area of Science:
- Immunology
- Gene Therapy
- Stem Cell Transplantation
Background:
- Autoimmune diseases are currently incurable, posing a significant challenge in medicine.
- Existing treatments like autologous bone marrow transplantation carry a risk of disease relapse.
Purpose of the Study:
- To propose a combination curative strategy for autoimmune diseases using hematopoietic stem cells and gene therapy.
- To establish immunological tolerance by inducing molecular chimerism with donor antigen presentation in the thymus.
Main Methods:
- Utilizing genetically engineered hematopoietic stem cells for transplantation.
- Leveraging transgenic antigen expression in the thymus under an MHC class II promoter to establish intrathymic tolerance.
Main Results:
- The proposed strategy aims to create molecular chimerism, leading to immunological tolerance.
- This method is expected to eliminate the risk of disease relapse associated with current treatments.
Conclusions:
- A combination of hematopoietic stem cells and gene therapy offers a potential curative strategy for autoimmune diseases.
- This novel approach promises to overcome the limitations of existing treatments by preventing disease relapse.